ONCAlert | Upfront Therapy for mRCC

Breast Cancer VIEW MORE >>

The FDA granted approval to countless treatments across cancer types throughout 2019 until the end of the year, with a final approval on December 31st for the first BRCA targeted therapy in pancreatic cancer. Following the excitement for a new year of further advances, Targeted Oncology followers on Twitter shared their thoughts on some of the most impactful FDA approvals in 2019.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.